AEMD Stock Summary and Trading Ideas (Aethlon Medical | NASDAQ:AEMD)

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Aethlon Medical trades on the NASDAQ stock market under the symbol AEMD.

As of January 23, 2026, AEMD stock price climbed to $3.28 with 295,795 million shares trading.

AEMD has a beta of 1.15, meaning it tends to be more sensitive to market movements. AEMD has a correlation of 0.02 to the broad based SPY ETF.

AEMD has a market cap of $3.19 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AEMD traded as high as $696.00 and as low as $2.22.

AEMD has underperformed the market in the last year with a return of -93.4%, while the SPY ETF gained +14.9%. In the last 3 month period, AEMD fell short of the market, returning -32.4%, while SPY returned +3.5%. However, in the most recent 2 weeks AEMD has outperformed the stock market by returning +33.3%, while SPY returned 0.0%.

AEMD support price is $2.83 and resistance is $3.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AEMD shares will trade within this expected range on the day.